322 results
Page 2 of 17
8-K
EX-4.2
ue5cm1p
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
424B5
61qksvdwkwy9
30 Nov 23
Prospectus supplement for primary offering
4:58pm
424B5
y46xh
28 Nov 23
Prospectus supplement for primary offering
4:06pm
8-K
EX-10.1
xfuhk0ckb5jn199
25 Sep 23
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-4.1
fk2z9mx7zh1 rn
25 Sep 23
Entry into a Material Definitive Agreement
4:06pm
424B5
przezd6etebyfdej1
25 Sep 23
Prospectus supplement for primary offering
6:02am
8-K
EX-10.1
0zmfzke9cjjik
19 May 23
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-1.1
05m2ns30bgzzn ifnj2z
12 May 22
Entry into a Material Definitive Agreement
8:31am
424B5
y7p64qvyxmdmr2xpd
12 May 22
Prospectus supplement for primary offering
8:30am
8-K
EX-10.1
ifvyxb f8wno4u
10 Jan 22
Departure of Directors or Certain Officers
4:28pm